Oligohydramnios is defined as an amniotic fluid volume below the 5th percentile for gestational age
Many studies report an increase in adverse neonatal outcomes in cases of oligohydramnios (meconium aspiration and admission to intensive care units). Indeed, according to some authors, the risk of cesarean section is twice as high in cases of oligohydramnios (RR, 2.16 [95% CI: 1.64 - 2.85]). The risk of admission to neonatal intensive care unit is higher in cases of oligohydramnios (RR, 1.71 [95% CI: 1.20 - 2.42]), as is the risk of meconium inhalation syndrome (RR, 2.83 [95% CI: 1.38 - 5.77]).
Regarding neonatal risk, it is important to investigate an association between mode of delivery and risk of perinatal asphyxia. This raises the question of the mode of delivery in cases of oligohydramnios.
The objective of this study is to investigate the factors associated with oligohydramnios and its inherent morbidity and mortality.
This study was conducted at a level 2 facility in Dakar, with an average annual delivery rate of 5500. This study was a retrospective nested case-control study within a simple cohort. The study was conducted over 10 years: from January 1, 2011, to December 31, 2021. We included all patients who delivered at the facility during the study period.
Cases were represented by women who developed oligohydramnios, diagnosed based on the ultrasound definition (measuring the deepest fluid pocket or calculating the amniotic fluid index). Controls consisted of pregnant women admitted to the maternity yard during the same period with normal amniotic fluid levels. Exclusion criteria included premature rupture of membranes, fetal malformations, multiple pregnancies, and intrauterine fetal demise.
The frequency of oligohydramnios ranges from 0.5% to 8%. The sample size for women with oligohydramnios was calculated using the following formula: n = (z/∆)2 × p(1 − p):
For a prevalence of 0.005, the required number of cases is 8, while for a prevalence of 0.08, n = 113 cases.
In rare exposures, at least 8 controls per case are needed for a sensitivity of 70%. We selected 20 controls per case to ensure very high sensitivity of the Odds Ratio (OR). In a nested case-control design, the OR is an unbiased estimator of the relative risk (RR) of a cohort.
We first defined the number of controls to select for each study year, then proceeded with randomization to select the controls for each year. We studied the biometric date and medical histories of mothers, pregnancy and delivery data, fetal outcomes, and pregnancy-related pathologies. Data were extracted from an e-Perinatal database using FileMaker® software. Patients’ information was recorded daily. The data were exported to Excel and analyzed using SPSS and R Studio 4.1.3 software. The diagnosis of oligohydramnios was based on ultrasound performed by senior obstetricians within the facility. Oligohydramnios was diagnosed when the deepest pocket was ≤2 cm or AFI ≤ 5 cm.
Continuous quantitative variables were described by their position and dispersion parameters. Qualitative variables were described by their proportions relative to the total. Data were compared using the chi-square test if normality conditions were met or non-parametric tests otherwise, as U Test of Mann-Whitney. We conducted Normality tests using the statistical software SPSS. When P > 0.05, the null hypothesis is accepted, and data are normally distributed.
The significance threshold was set at 0.05. We calculated the association strength using ORs.
Neonatal morbidity and mortality included all children who experienced perinatal asphyxia or perinatal death. Our study received approval from the local ethics committee.
Our study focused on 145 cases of oligohydramnios from a historical cohort of 56,775 patients. These cases were compared to 2953 controls.
The average age of the patients was comparable between the two groups (
Case |
Control |
P |
|
Age years (means ± SDa) |
27.75 ± 6.05 |
27.51 ± 6.24 |
0.944 |
Parity (means ± SDa) |
0.76 ± 1.1 |
1.41 ± 1.5 |
0.000 |
Uterine fundal high (means ± SDa) |
30.92 ± 2.4 |
32.72 ± 2.6 |
0.034 |
aStandard deviation.
We found that premature deliveries were nearly four times more frequent among the cases (OR = 3.79). The same observation applied to post-term deliveries, with an OR of 3.47. The prevalence of preeclampsia was seven times higher in this group compared to the control group (OR = 7.7 [5.12; 11.7]). This indicates a strong association between preeclampsia and the presence of oligohydramnios.
The prevalence of small-for-gestational-age (SGA) fetuses was four times lower in the control group (OR= 4.3 [3.04; 6.21]). Thus, in the case of oligohydramnios, there is a high risk of small for gestational age. A similar trend was observed with intrauterine growth restriction (IUGR). Labor was induced in 15.2% of patients with oligohydramnios. Cesarean delivery prevalence was higher among the cases than the controls: 77.2% versus 22.8% (OR= 3.4 [3.03; 3.78]).
The diagnosis of non-reassuring fetal status was made in 9.7% of cases and 6.2% of controls, without significant difference between the two groups. There was no difference in the rate of non-reassuring fetal status in two groups.
However, perinatal asphyxia was almost three times more frequent in infants born in the context of oligohydramnios compared to the controls. We observed a prevalence of 6.2% and 3.2%, respectively, with an OR = 2.7 [1.38; 5.30]. Thus, we noted a higher risk of perinatal asphyxia when there is oligohydramnios. The same trend was noted regarding morbidity and mortality. The neonatal morbimortality was three times more frequent among the cases: OR = 2.7 [1.51; 5.07] (
Case (%) |
Control (%) |
P |
OR [95% CI] |
|
Term of pregnancy |
||||
Terme |
69.0 |
89.4 |
- |
|
Preterm labor |
15.9 |
4.4 |
0.000 |
3.79 [2.57; 5.59] |
Postterme |
15.2 |
5.4 |
0.000 |
3.47 [2.26; 5.33] |
Preeclampsia |
25.5 |
4.2 |
0.000 |
7.70 [5.12; 11.7] |
Diabetes mellitus |
6.9 |
3.0 |
0.017 |
2.31 [1.20; 4.63] |
Small for gestational age |
46.2 |
16.5 |
0.000 |
4.32 [3.04; 6.21] |
Fetal growth restriction |
32.4 |
1.1 |
0.000 |
44.3 [23.6; 83.4] |
Labor induction |
15.2 |
3.4 |
0.000 |
4.51 [2.95; 6.99] |
Meconium-stained amniotic fluid |
3.4 |
11.1 |
0.017 |
2.30 [1.20; 4.63] |
Cesarean section |
77.2 |
22.8 |
0.000 |
3.41 [3.03; 3.78] |
Non-reassuring fetal status |
9.7 |
6.2 |
0.074NS |
1.61 [0.91; 2.86] |
Perinatal asphyxia |
6.2 |
2.3 |
0.007 |
2.73 [1.38; 5.30] |
Morbidity and mortality |
9.0 |
3.4 |
0.002 |
2.72 [1.51; 5.07] |
NS = not significant.
No factors associated with neonatal morbidity and mortality in cases of oligohydramnios were identified (
Morbidity and mortality (%) |
P |
|
Induction of labor |
||
Spontaneous induction |
9.1 |
0.952NS |
Artificial induction |
9.0 |
|
Mode of delivery |
||
Cesarean section |
8.0 |
0.495NS |
Vaginal birth |
12.1 |
|
Small for gestational age |
||
Yes |
13.4 |
0.073NS |
No |
9.0 |
|
Postterm labor |
||
Yes |
9.1 |
0.992NS |
No |
8.0 |
|
Preterm labor |
||
Yes |
13.0 |
0.747NS |
No |
8.0 |
|
Preeclampsia |
||
Yes |
8.1 |
0.867NS |
No |
5.6 |
NS = not significant.
Also, the small for gestational age does not present an additional risk of asphyxia compared to the eutrophic fetus in case of oligohydramnios. The contingency tables regarding labor induction, hypertension, and post-term pregnancies had fewer than five occurrences, making it impossible to determine an association or perform a stratified analysis (
This was a retrospective study, which may introduce information bias. Additionally, oligohydramnios is a rare condition, and even with an optimal sample size, subgroup analyses are sometimes not feasible.
One of the study’s strengths is that it was a nested case-control study within a cohort, ensuring good sampling.
We found significantly more pathological pregnancy outcomes in cases of oligohydramnios, including:
Labor induction and cesarean rates were higher in the oligohydramnios group. The prevalence of perinatal asphyxia was significantly higher in patients with oligohydramnios, and the same trend was observed for morbidity and mortality.
We examined the parameters that could impact neonatal morbidity and mortality in cases of oligohydramnios. Labor induction, delivery mode, gestational age, and SGA status were not associated with neonatal morbidity or mortality.
Jagatia et al., in a study based on 100 cases of oligohydramnios, report 25% of hypertensive disorders
Several studies have demonstrated a significant association between oligohydramnios and the prevalence of SGA infants. According to Locatelli et al.
However, other authors as Couanon et al.
In our study, we included isolated oligohydramnios and those associated with a pathology. This observation allows us to assume that the rate of SGA is linked to the underlying conditions.
In case of hypertensive disorders, fetal hypovolemia may lead to reduced fetal urine output. Moreover, the redistribution of blood flow to vital organs also explains the occurrence of oligohydramnios. It is now well recognized that some forms of hypertensive disorders during pregnancy may first manifest as fetal involvement. Thus, in cases of oligohydramnios, particularly when associated with a low-birth-weight fetus, it is important to screen for hypertensive disorders through proteinuria and ambulatory blood pressure monitoring. Based on these observations, should oligohydramnios lead to the reclassification of SGA fetuses as IUGR?
Many studies report a higher rate of labor induction
Regarding cesarean rates, the results are somewhat contradictory and raise questions about the exact reason for cesarean delivery: fetal hypoxia, labor induction, or a selection bias in clinical decision-making.
Conway et al.
The high cesarean section rate in the case arm may be inherent to the pathologies often associated with oligohydramnios. The risk of cesarean section delivery should not justify expectant management. We conclude that, in the presence of an obstetric complication indicating termination of pregnancy, artificial induction of labor may be performed.
In our series, the risk of perinatal asphyxia was 2.7 times higher in the oligohydramnios group. Similar conclusions were made by Zhang et al.
In light of our results, further prospective studies and more homogeneous meta-analyses are needed. Future studies should address the question of whether oligohydramnios justifies reclassifying SGA as IUGR.
Labor induction and cesarean delivery do not increase neonatal morbidity and mortality.
Oligohydramnios is significantly associated with several pathological obstetric conditions, including preterm delivery, post-term pregnancy, hypertensive disorders, maternal diabetes, SGA fetuses, and IUGR.
Furthermore, oligohydramnios increases the likelihood of interventions such as cesarean delivery and labor induction.
Finally, additional studies are needed to determine whether IUGR can also be defined by an estimated fetal weight below the 10th percentile combined with oligohydramnios.